A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

PHASE3CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

May 31, 2007

Conditions
COPD
Interventions
DRUG

Formoterol Fumarate

Trial Locations (52)

13030

Research Site, Camillus

19013

Research Site, Upland

23225

Research Site, Richmond

24210

Research Site, Abingdon

27607

Research Site, Raleigh

27909

Research Site, Elizabeth City

28207

Research Site, Charlotte

28801

Research Site, Asheville

29307

Research Site, Spartanburg

30309

Research Site, Atlanta

32720

Research Site, DeLand

33140

Research Site, Miami Beach

33603

Research Site, Tampa

33765

Research Site, Clearwater

35501

Research Site, Jasper

45231

Research Site, Cincinnati

45242

Research Site, Cincinnati

53209

Research Site, Milwaukee

53792

Research Site, Madison

55402

Research Site, Minneapolis

55905

Research Site, Rochester

60141

Research Site, Hines

61761

Research Site, Normal

63122

Research Site, St Louis

63141

Research Site, St Louis

66210

Research Site, Overland Park

66216

Research Site, Shawnee Mission

66606

Research Site, Topeka

73104

Research Site, Oklahoma City

75231

Research Site, Dallas

76712

Research Site, Waco

77030

Research Site, Houston

78750

Research Site, Austin

80033

Research Site, Wheat Ridge

80206

Research Site, Denver

83814

Research Site, Coeur d'Alene

89014

Research Site, Henderson

90620

Research Site, Buena Park

90813

Research Site, Long Beach

92120

Research Site, San Diego

92626

Research Site, Costa Mesa

92647

Research Site, Huntington Beach

94598

Research Site, Walnut Creek

95207

Research Site, Stockton

97213

Research Site, Portland

97504

Research Site, Medford

98405

Research Site, Tacoma

85006-2666

Research Site, Phoenix

02747

Research Site, North Dartmouth

07901

Research Site, Summit

02920

Research Site, Cranston

05403

Research Site, South Burlington

All Listed Sponsors
lead

Dey

INDUSTRY

NCT00280371 - A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD | Biotech Hunter | Biotech Hunter